Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone for Silicosis and Progressive Massive Fibrosis
NCT05118256Phase 2Unknown
- Sponsor
- INIBICA
- Start
- Nov 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in silicosis, progressive massive fibrosis (PMF), sponsored by INIBICA. Status: unknown.
02
Drugs
pirfenidone
03
Conditions
silicosisprogressive massive fibrosis (PMF)
Beyond the preview
Go deeper on NCT05118256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05118256.